Transformative all-stock transaction expected to present an estimated $200 million in run-rate cost synergies Combined company expected to have significant financial and operating leverage with $6.5 billion in Net Revenue and $1.5 billion in Adjusted EBITDA1, including estimated…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.